Sculptor Capital LP Alaunos Therapeutics, Inc. Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $128,443 - $215,834	-31,100 Reduced 85.44%	5,300 $22,000
Q2 2019 Aug 14, 2019	SELL	$3.98 - $6.2 $873,212 - $1.36 Million	-219,400 Reduced 85.77%	36,400 $212,000
Q1 2019 May 13, 2019	BUY	$2.0 - $4.4 $72,000 - $158,400	36,000 Added 16.38%	255,800 $0
Q4 2018 Feb 13, 2019	BUY	$1.61 - $3.62 $353,878 - $795,676	219,800 New	219,800 $411,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.